相似文献
1
Metachronous Osseous Metastases From Gliobliostoma Mutiforme: An Unusual Presentation.
Cureus. 2022 Feb 25;14(2):e22587. doi: 10.7759/cureus.22587. eCollection 2022 Feb.
2
Bone metastasis from glioblastoma: a systematic review.
J Neurooncol. 2022 Jul;158(3):379-392. doi: 10.1007/s11060-022-04025-4. Epub 2022 May 17.
3
Metastasis from glioblastoma multiforme: a meta-analysis.
Rev Assoc Med Bras (1992). 2019 Mar;65(3):424-433. doi: 10.1590/1806-9282.65.3.424. Epub 2019 Apr 11.
4
Multiple extracranial metastases from glioblastoma multiforme: a case report and literature review.
J Int Med Res. 2020 Jun;48(6):300060520930459. doi: 10.1177/0300060520930459.
5
Diffuse bony metastases at presentation in a child with glioblastoma multiforme. A case report.
Cancer. 1990 Jul 1;66(1):180-4. doi: 10.1002/1097-0142(19900701)66:1<180::aid-cncr2820660132>3.0.co;2-m.
6
Extracranial metastases in secondary glioblastoma multiforme: a case report.
BMC Neurol. 2020 Oct 21;20(1):382. doi: 10.1186/s12883-020-01959-y.
7
Adrenocortical tumors: results of treatment and study of Weiss's score as a prognostic factor.
Rev Hosp Clin Fac Med Sao Paulo. 2002 Nov-Dec;57(6):251-6. doi: 10.1590/s0041-87812002000600002. Epub 2003 Feb 17.
8
Variations of Weiss's ring.
Retina. 2001;21(3):243-6. doi: 10.1097/00006982-200106000-00008.
9
Presentation of Two Cases with Early Extracranial Metastases from Glioblastoma and Review of the Literature.
Case Rep Oncol Med. 2016;2016:8190950. doi: 10.1155/2016/8190950. Epub 2016 May 9.
10
A Rare Case of Glioblastoma Multiforme with Osseous Metastases.
Case Rep Oncol Med. 2017;2017:2938319. doi: 10.1155/2017/2938319. Epub 2017 Oct 19.
引用本文的文献
1
A Case of Glioblastoma, Isocitrate Dehydrogenase Wild Type, With Widely Disseminated Osseous Metastasis.
Cureus. 2022 Sep 5;14(9):e28803. doi: 10.7759/cureus.28803. eCollection 2022 Sep.
本文引用的文献
1
Regorafenib in Recurrent Glioblastoma Patients: A Large and Monocentric Real-Life Study.
Cancers (Basel). 2021 Sep 21;13(18):4731. doi: 10.3390/cancers13184731.
2
Metastasis from glioblastoma multiforme: a meta-analysis.
Rev Assoc Med Bras (1992). 2019 Mar;65(3):424-433. doi: 10.1590/1806-9282.65.3.424. Epub 2019 Apr 11.
3
Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial.
Lancet Oncol. 2019 Jan;20(1):110-119. doi: 10.1016/S1470-2045(18)30675-2. Epub 2018 Dec 3.
4
Extracranial Metastases of a Cerebral Glioblastoma: A Case Report and Review of the Literature.
Case Rep Oncol. 2018 Aug 28;11(2):591-600. doi: 10.1159/000492111. eCollection 2018 May-Aug.
5
Extracranial metastasis of gliobastoma: Three illustrative cases and current review of the molecular pathology and management strategies.
Mol Clin Oncol. 2015 May;3(3):479-486. doi: 10.3892/mco.2015.494. Epub 2015 Jan 23.
6
Use of bevacizumab in recurrent glioblastoma.
CNS Oncol. 2015;4(3):157-69. doi: 10.2217/cns.15.8. Epub 2015 Apr 23.
7
An individual patient data meta-analysis on characteristics, treatments and outcomes of glioblastoma/ gliosarcoma patients with metastases outside of the central nervous system.
PLoS One. 2015 Apr 10;10(4):e0121592. doi: 10.1371/journal.pone.0121592. eCollection 2015.
8
Brain tumor cells in circulation are enriched for mesenchymal gene expression.
Cancer Discov. 2014 Nov;4(11):1299-309. doi: 10.1158/2159-8290.CD-14-0471. Epub 2014 Aug 19.
9
Hematogenous dissemination of glioblastoma multiforme.
Sci Transl Med. 2014 Jul 30;6(247):247ra101. doi: 10.1126/scitranslmed.3009095.
10
Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial.
Lancet Oncol. 2014 Aug;15(9):943-53. doi: 10.1016/S1470-2045(14)70314-6. Epub 2014 Jul 15.
Zotero 插件
